151 related articles for article (PubMed ID: 20739034)
1. The pre-requisite of a second-generation glioma PET biomarker.
Borbely K; Wintermark M; Martos J; Fedorcsak I; Bognar L; Kasler M
J Neurol Sci; 2010 Nov; 298(1-2):11-6. PubMed ID: 20739034
[TBL] [Abstract][Full Text] [Related]
2. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Gulyás B; Halldin C
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
[TBL] [Abstract][Full Text] [Related]
3. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
Spence AM; Muzi M; Mankoff DA; O'Sullivan SF; Link JM; Lewellen TK; Lewellen B; Pham P; Minoshima S; Swanson K; Krohn KA
J Nucl Med; 2004 Oct; 45(10):1653-9. PubMed ID: 15471829
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
6. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
[TBL] [Abstract][Full Text] [Related]
7. [Value of 18F-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy].
Chen YR; Li WX; Lin YR; Chen LH
Ai Zheng; 2004 Oct; 23(10):1210-2. PubMed ID: 15473938
[TBL] [Abstract][Full Text] [Related]
8. PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.
Kläsner BD; Krause BJ; Beer AJ; Drzezga A
Expert Rev Anticancer Ther; 2010 May; 10(5):609-13. PubMed ID: 20469990
[No Abstract] [Full Text] [Related]
9. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
[TBL] [Abstract][Full Text] [Related]
10. [Fluoroethylthyrosine 18F PET in the detection of brain tumours].
Nataf V; Kerrou K; Balogova S; Pene F; Huchet V; Gutman F; Prignon A; Muresan IP; Giannesini C; Izrael V; Schlienger M; Talbot JN
Bull Cancer; 2010 May; 97(5):495-506. PubMed ID: 20374979
[TBL] [Abstract][Full Text] [Related]
11. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
12. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
13. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
[TBL] [Abstract][Full Text] [Related]
14. Differentiation between malignant transformation and tumour recurrence by (68)Ga-bombesin and (18)F-FDG-PET, in patients with low grade gliomas.
Seiz M; Dimitrakopoulou-Strauss A; Schubert GA; Weinmann C; Strauss LG; Eisenhut M; Tuettenberg J
Hell J Nucl Med; 2008; 11(3):149-52. PubMed ID: 19081856
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
[TBL] [Abstract][Full Text] [Related]
16. Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors.
Borja AJ; Saini J; Raynor WY; Ayubcha C; Werner TJ; Alavi A; Revheim ME; Nagaraj C
PET Clin; 2022 Jul; 17(3):431-451. PubMed ID: 35662494
[TBL] [Abstract][Full Text] [Related]
17. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
Albert NL; Weller M; Suchorska B; Galldiks N; Soffietti R; Kim MM; la Fougère C; Pope W; Law I; Arbizu J; Chamberlain MC; Vogelbaum M; Ellingson BM; Tonn JC
Neuro Oncol; 2016 Sep; 18(9):1199-208. PubMed ID: 27106405
[TBL] [Abstract][Full Text] [Related]
18. [Validation of MRI and 18F-FDG-PET coregistration in patients with primary brain tumors].
Ortega-López N; Mendoza-Vásquez RG; Adame-Ocampo G; Alexanderson-Rosas E; Cayetano-Alcaraz AA; Angel-Celis M
Gac Med Mex; 2007; 143(4):309-16. PubMed ID: 17969839
[TBL] [Abstract][Full Text] [Related]
19. Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET.
Tsuchida T; Takeuchi H; Okazawa H; Tsujikawa T; Fujibayashi Y
Nucl Med Biol; 2008 Feb; 35(2):171-6. PubMed ID: 18312826
[TBL] [Abstract][Full Text] [Related]
20. Reply to "[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.
Langen KJ; Galldiks N
Neuro Oncol; 2013 Jul; 15(7):816-7. PubMed ID: 23749786
[No Abstract] [Full Text] [Related]
[Next] [New Search]